All Work

Chris Lange

SoulCycle Readies for IPO

SoulCycle has amended its filing with the Securities and Exchange Commision (SEC) for its initial public offering (IPO).

Chris Lange · 11 years ago

Cara Therapeutics Posts Strong Phase 2 Results

Cara Therapeutics saw its stock rise in Wednesday’s session on statistically significant Phase 2 results, but the delight of investors may be short lived.

Chris Lange · 11 years ago

Mixed Views on Major Biotech Short Interest

The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.

Chris Lange · 11 years ago

Baxalta Rises on FDA Approval

Baxalta was rising in Wednesday’s trading session on news of a key U.S. Food and Drug Administration (FDA) approval.

Chris Lange · 11 years ago

What to Watch For in Adobe Earnings

Adobe Systems is scheduled to report its fiscal fourth-quarter financial results after the markets close on Thursday.

Chris Lange · 11 years ago

What 2016 Has in Store for Cybersecurity Firms

Coalfire, a leader in cybersecurity risk management and compliance services, has provided a few predictions about how 2016 will affect the cybersecurity landscape.

Chris Lange · 11 years ago